These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34104448)

  • 1. Clozapine-associated neutropenia following augmentation with sodium valproate.
    Jakobsen MI; Grønborg H; Hansen HV; Fink-Jensen A
    SAGE Open Med Case Rep; 2021; 9():2050313X211019791. PubMed ID: 34104448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate and clozapine induced neutropenia: A case control study using register data.
    Malik S; Lally J; Ajnakina O; Pritchard M; Krivoy A; Gaughran F; Shetty H; Flanagan RJ; MacCabe JH
    Schizophr Res; 2018 May; 195():267-273. PubMed ID: 28882687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
    J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine.
    Morrow O; Gibson L; Bhamra M; David AS; Posporelis S
    Ther Adv Psychopharmacol; 2020; 10():2045125320956414. PubMed ID: 32973999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-titration rates after clozapine-induced neutropenia or agranulocytosis: A case report and literature review.
    Boazak M; Kahn B; Cox L; Ragazino J; Goldsmith DR; Cotes RO
    Clin Schizophr Relat Psychoses; 2018 Jun; ():. PubMed ID: 29944418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C; Adesanya A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
    Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW
    Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis.
    Voulgari C; Giannas R; Paterakis G; Kanellou A; Anagnostopoulos N; Pagoni S
    Case Rep Med; 2015; 2015():703218. PubMed ID: 25755670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report.
    Paraschakis A
    Clin Neuropharmacol; 2014; 37(2):60-1. PubMed ID: 24614672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
    Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
    Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.